29 Oct The Risk Benefit Analysis of Mesenchymal Stem Cell Therapy
Posted at 17:51h
in Amniotic Stem Cells, Regenerative Medicine, stem cell therapy, Umbilical Cord Stem Cells
0 Comments
Over the past eight years, R3 Stem Cells’ Centers of Excellence in the US, Mexico and Pakistan have administered over 15,000 stem cell and exosome procedures. With eight years of experience and over 15 IRB Approved protocols, R3 Stem Cell’s Centers are trusted by patients...